PressAugust 21, 2020 ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines
PressAugust 21, 2020 Psychedelic Research Fundraising Campaign Attracts $30 Million in Donations in 6 Months, Prepares MDMA-Assisted Psychotherapy for FDA Approval
InterviewsAugust 20, 2020 A New Approach to Psilocybin Production That’s Cheaper and More Precise: Mimosa CEO Jim Keim
PressAugust 19, 2020 PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights
PressAugust 18, 2020 Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
InterviewsAugust 14, 2020 Fighting Depression with Targeted, Next Generation Psychedelics: A Conversation with Bright Minds CEO Ian McDonald
PressAugust 13, 2020 Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD
PressAugust 12, 2020 GHP Noetic Science-Psychedelic Pharma Inc. Announces Closing of Initial Public Offering
PressAugust 12, 2020 Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector
PressAugust 11, 2020 USF Connect’s Tampa Bay Technology Incubator Propels Homegrown Researchers at Biotech Startup Psilera Bioscience
PressAugust 10, 2020 Cybin Applauds TheraPsil’s Advocacy to Bring Psilocybin Therapy to Palliative Care of Canadian Patients
PressAugust 6, 2020 MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy
PressAugust 5, 2020 Nutritional High Announces Settlement of Payables and Update on Psychedelic Sciences Corp Acquisition.
PressAugust 5, 2020 Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule
